Imraldi vs. Amjevita

Imraldi (adalimumab injection, solution) and Amjevita (adalimumab-atto) injection are tumor necrosis factor (TNF) blockers used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis, and plaque psoriasis.

Side effects of Imraldi and Amjevita that are similar include infections (e.g. upper respiratory, sinusitis, urinary tract infection), injection site reactions, headache, and rash.

Side effects of Amjevita that are different from Imraldi include nausea, abdominal pain, and back pain.

Both Imraldi and Amjevita may interact with abatacept, anakinra, and live vaccines.

Side effects of Imraldi include:

• infections (e.g. upper respiratory, sinusitis),
• injection site reactions,
• headache, and
• rash

Common side effects of Amjevita include:

• infections (e.g. upper respiratory, sinusitis, urinary tract infection),
• injection site reactions,
• headache,
• rash,
• nausea,
• abdominal pain, or
• back pain.

Imraldi (adalimumab injection, solution) is a tumor necrosis factor (TNF) blocker used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis, and plaque psoriasis.

Amjevita (adalimumab-atto) injection is a tumor necrosis factor (TNF) blocker indicated for treatment of rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), adult Crohn's disease (CD), ulcerative colitis (UC), and plaque psoriasis (Ps).

Imraldi may interact with other medicines such as:

• abatacept,
• anakinra, and
• live vaccines

Tell your doctor all medications and supplements you use.

Amjevita may interact with:

• anakinra,
• abatacept, or
• live vaccines

The dose of Imraldi for rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis is 40 mg every other week.

The dose of Imraldi for juvenile idiopathic arthritis for patients 30 kg (66 lbs.) or greater and from 4 to 17 years of age is 40 mg every other week.

The initial dose of Imraldi for adult Crohn's disease and ulcerative colitis is 160 mg (four 40 mg injections in one day or two 40 mg injections per day for two consecutive days), and the second dose two weeks later (Day 15) is 80 mg. Two weeks later (Day 29): Begin a maintenance dose of 40 mg every other week.

The initial dose of Imraldi for plaque psoriasis is an 80 mg initial dose, followed by 40 mg every other week starting one week after initial dose.

The dose of Amjevita depends on the condition being treated.